Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome.
Trakada G, Kastritis E, Gavriatopoulou M, Velentza L, Fotiou D, Ziogas DC, Panagiotidis I, Eleutherakis-Papaiakovou E, Roussou M, Migkou M, Kanellias N, Ntanasis-Stathopoulos I, Kallianos A, Terpos E, Dimopoulos MA. Trakada G, et al. Among authors: dimopoulos ma. Ann Hematol. 2019 Jun;98(6):1427-1434. doi: 10.1007/s00277-019-03641-x. Epub 2019 Mar 5. Ann Hematol. 2019. PMID: 30834954
Thalidomide in the treatment of multiple myeloma.
Kastritis E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Best Pract Res Clin Haematol. 2007 Dec;20(4):681-99. doi: 10.1016/j.beha.2007.09.001. Best Pract Res Clin Haematol. 2007. PMID: 18070713 Review.
Treatment of relapsed/refractory multiple myeloma.
Kastritis E, Palumbo A, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Semin Hematol. 2009 Apr;46(2):143-57. doi: 10.1053/j.seminhematol.2009.01.004. Semin Hematol. 2009. PMID: 19389498 Review.
Renal insufficiency and failure.
Dimopoulos MA, Terpos E. Dimopoulos MA, et al. Hematology Am Soc Hematol Educ Program. 2010;2010:431-6. doi: 10.1182/asheducation-2010.1.431. Hematology Am Soc Hematol Educ Program. 2010. PMID: 21239831
Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy.
Migkou M, Kastritis E, Roussou M, Gkotzamanidou M, Gavriatopoulou M, Nikitas N, Mparmparoussi D, Matsouka C, Gika D, Terpos E, Dimopoulos MA. Migkou M, et al. Among authors: dimopoulos ma. Eur J Haematol. 2011 Oct;87(4):323-9. doi: 10.1111/j.1600-0609.2011.01659.x. Epub 2011 Aug 26. Eur J Haematol. 2011. PMID: 21631590
Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents.
Tasidou A, Roussou M, Terpos E, Kastritis E, Gkotzamanidou M, Gavriatopoulou M, Migkou M, Eleutherakis-Papaiakovou E, Nikitas N, Anagnostou D, Dimopoulos MA. Tasidou A, et al. Among authors: dimopoulos ma. Am J Hematol. 2012 Jul;87(7):734-6. doi: 10.1002/ajh.23223. Epub 2012 May 6. Am J Hematol. 2012. PMID: 22565393 Free article.
Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
Moulopoulos LA, Dimopoulos MA, Kastritis E, Christoulas D, Gkotzamanidou M, Roussou M, Koureas A, Migkou M, Gavriatopoulou M, Eleutherakis-Papaiakovou E, Gika D, Koutoulidis V, Terpos E. Moulopoulos LA, et al. Among authors: dimopoulos ma. Am J Hematol. 2012 Sep;87(9):861-4. doi: 10.1002/ajh.23258. Epub 2012 May 28. Am J Hematol. 2012. PMID: 22641455 Free article.
Current treatments for renal failure due to multiple myeloma.
Kastritis E, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Expert Opin Pharmacother. 2013 Aug;14(11):1477-95. doi: 10.1517/14656566.2013.803068. Epub 2013 May 25. Expert Opin Pharmacother. 2013. PMID: 23705905 Review.
1,275 results